IMMUNOASSAY FOR CYCLOPROPYLINDOLE BASED SYNTHETIC CANNABINOIDS, METABOLITES AND DERIVATIVES THEREOF
申请人:Randox Laboratories Limited
公开号:US20140287441A1
公开(公告)日:2014-09-25
The invention relates to the detection and quantification of cyclopropylindole based synthetic cannabinoids UR-144 and XLR-11 by providing antibodies based on novel immunogens. These antibodies can be incorporated into methods and kits for the detection of UR-144, XLR-11 and their metabolites.
该发明涉及基于新型免疫原的抗体,用于检测和定量环丙基吲哚类合成大麻素UR-144和XLR-11。这些抗体可以应用于检测UR-144、XLR-11及其代谢物的方法和试剂盒中。